Search clinical trials for: Physiological and biological markers

Total 474012 results

Fondazione Italiana Linfomi - ETS

Recruiting

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance (FIL_FollVax22)

Follicular Lymphoma

Italy
Istituto Auxologico Italiano

Recruiting

Potential Predictive Biological Markers of Major Depression Response to Citalopram Therapy in Anorexia Nervosa. (ANCITA)

Anorexia Nervosa

Italy
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Recruiting

MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers (AeCE)

Serum Biomarkers | Vascular Reactivity

United States
National Cancer Institute (NCI)

Active, not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Glioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditions

United States, Puerto Rico, Guam
Ruhr University of Bochum
German Research Foundation; University of Oxford; University of Salzburg

Completed

The Association Between Physical Sensations and Thinking Styles

Panic Disorder

Germany
University of Chicago

Completed

The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury

Acute Kidney Failure

United States
National Science Council, Taiwan

Completed

Melatonin Receptor Agonist and Peripheral Biological Markers

Insomnia
Assiut University

Completed

Implications of Different Analgesic Models on Inflammatory Markers After Laparoscopic Cholecystectomy

Perioperative Pain

Egypt
Cairo University

Unknown

Effect of Double Antibiotic Paste Versus Calcium Hydroxide on RANKL/OPG Levels

Biological Markers
University of California, San Diego

Completed

Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivors

Breast Neoplasms

United States
Menarini International Operations Luxembourg SA

Completed

Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout (FORWARD)

Gout

Poland, Serbia, Germany, Italy, Netherlands, Romania
Medical University of South Carolina
Takeda Pharmaceuticals North America, Inc.

Completed

Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes

Diabetes

United States
Massachusetts General Hospital

Completed

Biological Markers of Response to Treatment in Major Depressive Disorder

Major Depressive Disorder
P.O. Witteveen
Erasmus Medical Center; The Netherlands Cancer Institute

Terminated

Biomarker Development for Response Prediction by DNA Mutational Analysis (CPCT-01)

Neoplasm Metastasis

Netherlands
Erasmus Medical Center
Maastricht University Medical Center; Catharina Ziekenhuis Eindhoven; Albert... and other collaborators

Unknown

Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol (TopIC-2)

Cervical Intraepithelial Neoplasia

Netherlands
University of Pittsburgh
Schering-Plough

Terminated

Pilot Study of IFN α2b for Melanoma Patients

Melanoma

United States
Emory University
Cystic Fibrosis Foundation

Completed

Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study) (DISC)

Respiratory Tract Infections | Cystic Fibrosis

United States
Paulista University

Completed

Impact of a Triclosan-containing Toothpaste During the Progression of Experimental Peri-implant Mucositis

Biological Markers; Dental Implants; Cytokines; Triclosan; Toothpastes; Peri-Implantitis; Microbiology
TNO
Charles University, Czech Republic; University of Oslo; Lund University; Universitaire... and other collaborators

Active, not recruiting

The Nutrition Researcher Cohort 2014 Study (NRC250)

Biological Markers | Health | Nutritional Physiological Phenomena

Ireland, Denmark, Finland, Austria, United Kingdom, Belgium, Czechia, France, Italy, Netherlands, Spain, Switzerland
Seattle Children's Hospital
Cures Within Reach

Unknown

Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors (SEED)

Recurrent Childhood Brain Tumor

United States
Samsung Medical Center

Unknown

Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness (PG)

Depression | Antidepressant Drug Adverse Reaction

Korea, Republic of
National Cheng-Kung University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan)

Completed

Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in High Risk for Cardiovascular Disease

Cardiovascular Diseases

Taiwan
National Cheng-Kung University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan)

Unknown

Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease

Coronary Artery Disease

Taiwan
Assistance Publique - Hôpitaux de Paris
Pfizer; National Cancer Institute, France

Terminated

Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma (PREINSUT)

Metastatic Renal Cell Carcinoma

France
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.

Lung Cancer

China
Janssen Research & Development, LLC

Completed

A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's Disease

Healthy | Alzheimer Disease

Netherlands, Belgium
Assistance Publique - Hôpitaux de Paris

Completed

An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer (PROSUT)

Prostatic Neoplasms | Neoplasms, Hormone-Dependent | Survival Rate | Disease-Free Survival | Tumor Markers, Biological

France
Assistance Publique - Hôpitaux de Paris

Terminated

Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve (IROCHIM)

Infertility

France
Shanghai Mental Health Center
H. Lundbeck A/S

Completed

Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease

Alzheimer's Disease

China
Takeda

Completed

Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease

Cardiovascular Diseases
Clinvest
Ortho-McNeil Neurologics, Inc.

Completed

Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers

Migraine | Sinusitis

United States
Xuanwu Hospital, Beijing
Merck Serono Co., Ltd., China; Institute of Zoology, Chinese Academy of Sciences and other collaborators

Not yet recruiting

Pilot Study on Evaluating the Geroprotective Effect of Metformin (AGE-M)

Aging | Metformin

China
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Advanced Pancreatic Adenocarcinoma | Unresectable Pancreatic Ductal Adenocarcinoma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular Lymphoma | Refractory Grade 2 Follicular Lymphoma | Refractory Grade 3a Follicular Lymphoma

United States
Bruce Cree
Kyverna Therapeutics

Recruiting

A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis

Progressive Multiple Sclerosis

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia

Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia

United States
Ohio State University Comprehensive Cancer Center

Recruiting

Manipulating E-Cigarette Nicotine to Promote Public Health

Tobacco-Related Carcinoma

United States
Jonsson Comprehensive Cancer Center
Telix Pharmaceuticals (Innovations) Pty Limited

Not yet recruiting

An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer

Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Sarcomatoid Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Stage II Renal Cell Cancer

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation

Thyroid Gland Follicular Carcinoma | Thyroid Gland Papillary Carcinoma | Thyroid Gland Oncocytic Carcinoma

United States
University of Washington

Not yet recruiting

Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma

Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage II Marginal Zone Lymphoma | Ann Arbor Stage III Marginal Zone Lymphoma and other conditions

United States
King Saud University

Not yet recruiting

Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes

Osteoporosis | Diabetes Type 2
Roswell Park Cancer Institute

Not yet recruiting

Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Unresectable Triple-Negative Breast Carcinoma

United States
Auburn University
National Institute on Drug Abuse (NIDA); Wayne State University

Not yet recruiting

Cannabinoids and Biological Reactivity to Stress (COBRAS)

Cannabis Use Disorder
Ospedale San Raffaele
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Recruiting

Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis (BioMol-MA)

Non-Tuberculous Mycobacterial Pneumonia | Cystic Fibrosis Lung

Italy
United States Air Force Research Laboratory
Ohio State University; Uniformed Services University of the Health Sciences; The...

Recruiting

Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices

Physiological Wellness

United States
Shanghai Institute Of Biological Products
Victoria Biomedical Research Institute

Not yet recruiting

Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months

Measles-Mumps-Rubella
Diakonhjemmet Hospital
Vestre Viken Hospital Trust; Hormone Laboratory, Aker University Hospital,...

Not yet recruiting

Dynamics in Bone Turnover Markers During and After Short-term Glucocorticoid Treatment in Patients With an Inflammatory Joint Disease (BOOGIE)

Osteoporosis | Inflammatory Rheumatism | Osteoporosis, Steroid Induced
National Cancer Institute (NCI)

Not yet recruiting

Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer

Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Undifferentiated Carcinoma | Recurrent Ovarian Clear Cell Adenocarcinoma | Recurrent Ovarian Undifferentiated Carcinoma and other conditions
Narendranath Epperla
Eli Lilly and Company

Not yet recruiting

Pirtobrutinib With Rituximab for the Treatment of Newly Diagnosed Marginal Zone Lymphoma

Marginal Zone Lymphoma

United States
Mayo Clinic

Recruiting

Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer

Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma

United States

Search clinical trials for: Physiological and biological markers

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations